Renivace and blood chloride decreased Patient Reports February 13, 2012

Renivace Side Effects Report #4963544-X
Renivace side effect was reported by a Physician from JAPAN on Mar 14, 2006. Male patient, 56 years of age, weighting 103.6 lb, was diagnosed with glomerulonephritis membranous and was treated with Renivace. After drug was administered, patient experienced the following side effects: aspartate aminotransferase decreased, blood chloride decreased, blood cholesterol increased, blood creatinine decreased, blood lactate dehydrogenase increased, blood potassium decreased, blood pressure diastolic decreased, blood sodium decreased, blood urine present. Renivace dosage: unknown. During the same period patient was treated with BREDININ, SYNTHEPEN, GASTER, GASLON N, GLYCYRON, ASPARA K, PERSANTIN, MEDROL. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4978416-4
Renivace side effect was reported by a Health Professional from JAPAN on Mar 29, 2006. Male patient, 56 years of age, weighting 103.6 lb, was diagnosed with glomerulonephritis membranous and was treated with Renivace. After drug was administered, patient experienced the following side effects: aspartate aminotransferase decreased, blood chloride decreased, blood cholesterol increased, blood creatinine decreased, blood lactate dehydrogenase increased, blood potassium decreased, blood pressure diastolic decreased, blood sodium decreased, blood urine present. Renivace dosage: unknown. During the same period patient was treated with MEDROL, SYNTHEPEN, PERSANTIN, GLYCYRON, ASPARA K, GASLON N, GASTER, BREDININ. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4853149-3
Renivace side effect was reported by a Physician from JAPAN on Nov 24, 2005. Male patient, weighting 12.13 lb, was diagnosed with cardioplegia and was treated with Renivace. After drug was administered, patient experienced the following side effects: anuria, blood chloride decreased, blood potassium decreased, blood pressure systolic decreased, blood sodium decreased, hypotension, renal failure acute. Renivace dosage: 0.5 MG BID PO. During the same period patient was treated with MINOCYCLINE, DOBUTREX, FRANDOL S, LASIX, ALDACTONE. Patient recovered.

Renivace Side Effects Report #4691070-4
Renivace side effect was reported by a Physician from on May 25, 2005. Male patient, 73 years of age, weighting 99.21 lb, was diagnosed with cardiac failure, atrial fibrillation  and was treated with Renivace. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood aldosterone increased, blood chloride decreased, blood osmolarity decreased, blood pressure diastolic decreased, cardiac output decreased, electrocardiogram st segment depression, haematocrit decreased, inappropriate antidiuretic hormone secretion. Renivace dosage: unknown. During the same period patient was treated with ALDACTONE, DIGOSIN, VERAPAMIL. Patient was hospitalized. Patient recovered.


Renivace Side Effects Report #4738007-7
Renivace side effect was reported by a Physician from JAPAN on July 21, 2005. Male patient, 73 years of age, weighting 99.21 lb, was diagnosed with cardiac failure and was treated with Renivace. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood aldosterone increased, blood antidiuretic hormone increased, blood chloride decreased, blood osmolarity decreased, blood pressure diastolic decreased, electrocardiogram st segment depression, haematocrit decreased, hyponatraemia. Renivace dosage: unknown. During the same period patient was treated with ALDACTONE, DIGOSIN, VERAPAMIL. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4715569-7
Renivace side effect was reported by a Physician from JAPAN on June 27, 2005. Female patient, 19 years of age, weighting 66.14 lb, was diagnosed with cardiac failure and was treated with Renivace. After drug was administered, patient experienced the following side effects: anuria, aspartate aminotransferase increased, beta-n-acetyl-d-glucosaminidase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood chloride decreased, blood lactate dehydrogenase increased, blood potassium increased, blood pressure systolic decreased. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with MILRILA, LASIX, ALDACTONE, HALFDIGOXIN, NEUQUINONE, ZYLORIC. Patient recovered.

Renivace Side Effects Report #4737007-0
Renivace side effect was reported by a Physician from JAPAN on July 21, 2005. Female patient, 19 years of age, weighting 66.14 lb, was diagnosed with cardiac failure and was treated with Renivace. After drug was administered, patient experienced the following side effects: anuria, blood alkaline phosphatase increased, blood bilirubin increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased, blood urea increased. Renivace dosage: 2.5 MG BID PO. During the same period patient was treated with MILRILA, LASIX, ALDACTONE, HALFDIGOXIN, NEUQUINONE, ZYLORIC. Patient recovered.

Renivace Side Effects Report #4644503-3
Renivace side effect was reported by a Physician from on Apr 06, 2005. Male patient, 78 years of age, weighting 99.21 lb, was diagnosed with atrial fibrillation , cardiac failure and was treated with Renivace. After drug was administered, patient experienced the following side effects: blood aldosterone increased, blood antidiuretic hormone increased, blood chloride decreased, blood osmolarity decreased, blood pressure diastolic decreased, blood sodium decreased, electrocardiogram st segment depression, haematocrit decreased, heart rate increased. Renivace dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, DIGOXIN, VERAPAMIL. Patient was hospitalized. Patient recovered.